£30.5 M

Redx Pharma Revenue FY, 2017
Redx Pharma Net income (FY, 2017)1.5 M
Redx Pharma EBITDA (FY, 2017)2.3 M
Redx Pharma EBIT (FY, 2017)2 M
Redx Pharma Cash, 30-Sep-201723.8 M

Redx Pharma Income Statement

Annual

GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.3m30.5m

Operating expense total

4.9m28.5m

EBITDA

(3.5m)(9.2m)(14.7m)2.3m

EBITDA margin, %

(272%)8%

EBIT

(3.6m)(4.0m)(9.4m)(14.9m)2.0m

EBIT margin, %

(276%)6%

Pre tax profit

(3.8m)(4.3m)(8.8m)(15.4m)1.6m

Income tax expense

389.2k910.0k650.0k(114.0k)(118.0k)

Net Income

(3.4m)(3.4m)(8.2m)(15.5m)1.5m

Redx Pharma Balance Sheet

Annual

GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

515.8k45.8k1.0m2.9m9.4m5.8m23.8m

Accounts Receivable

112.9k331.9k2.7m114.0k452.0k469.0k

Current Assets

628.7k377.7k4.4m6.6m12.3m7.9m27.0m

PP&E

44.9k32.0k327.2k130.0k353.0k533.0k222.0k

Goodwill

309.0k309.0k309.0k

Total Assets

967.6k688.1k5.0m7.1m13.8m9.4m27.7m

Accounts Payable

1.0m483.2k1.4m1.2m1.6m1.6m4.0m

Current Liabilities

1.0m483.2k4.5m5.2m4.1m7.7m13.4m

Non-Current Liabilities

865.3k2.0m

Total Debt

2.0m

Total Liabilities

1.0m1.3m4.5m5.2m6.1m7.7m13.4m

Additional Paid-in Capital

3.5k4.1k5.6k7.0k650.0k936.0k1.3m

Retained Earnings

(3.4m)(3.4m)(8.2m)(15.5m)1.5m

Total Equity

(34.9k)(660.4k)415.1k1.8m7.7m1.7m14.3m

Debt to Equity Ratio

1.2 x

Debt to Assets Ratio

0.2 x

Financial Leverage

-27.7 x-1 x11.9 x3.9 x1.8 x5.5 x1.9 x

Redx Pharma Cash Flow

Annual

GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(3.4m)(3.4m)(8.2m)(15.5m)1.5m

Cash From Operating Activities

(3.9m)(2.2m)(6.5m)(12.5m)14.1m

Cash From Financing Activities

5.2m4.1m13.4m9.3m4.0m

Net Change in Cash

968.1k1.9m6.5m(3.7m)18.0m

Income Taxes Paid

910.0k650.0k(114.0k)

Redx Pharma Ratios

GBPY, 2017

Revenue/Employee

210.2k

Financial Leverage

1.9 x
Report incorrect company information